Ronsard Larance, Ganguli Nilanjana, Singh Vivek K, Mohankumar Kumaravel, Rai Tripti, Sridharan Subhashree, Pajaniradje Sankar, Kumar Binod, Rai Devesh, Chaudhuri Suhnrita, Coumar Mohane S, Ramachandran Vishnampettai G, Banerjea Akhil C
Laboratory of Virology, National Institute of ImmunologyDelhi, India.
Department of Microbiology, University College of Medical Sciences and Guru Teg Bahadur HospitalDelhi, India.
Front Microbiol. 2017 Apr 21;8:706. doi: 10.3389/fmicb.2017.00706. eCollection 2017.
HIV-1 evades host defense through mutations and recombination events, generating numerous variants in an infected patient. These variants with an undiminished virulence can multiply rapidly in order to progress to AIDS. One of the targets to intervene in HIV-1 replication is the -activator of transcription (Tat), a major regulatory protein that transactivates the long terminal repeat promoter through its interaction with -activation response (TAR) RNA. In this study, HIV-1 infected patients ( = 120) from North India revealed Ser46Phe (20%) and Ser61Arg (2%) mutations in the Tat variants with a strong interaction toward TAR leading to enhanced transactivation activities. Molecular dynamics simulation data verified that the variants with this mutation had a higher binding affinity for TAR than both the wild-type Tat and other variants that lacked Ser46Phe and Ser61Arg. Other mutations in Tat conferred varying affinities for TAR interaction leading to differential transactivation abilities. This is the first report from North India with a clinical validation of CD4 counts to demonstrate the influence of Tat genetic variations affecting the stability of Tat and its interaction with TAR. This study highlights the co-evolution pattern of Tat and predominant nucleotides for Tat activity, facilitating the identification of genetic determinants for the attenuation of viral gene expression.
HIV-1通过突变和重组事件逃避宿主防御,在受感染患者体内产生大量变体。这些毒力未减的变体能够迅速增殖,进而发展为艾滋病。干预HIV-1复制的靶点之一是转录激活因子(Tat),它是一种主要的调节蛋白,通过与反式激活应答(TAR)RNA相互作用来反式激活长末端重复启动子。在本研究中,来自印度北部的120例HIV-1感染患者的Tat变体中发现了Ser46Phe(20%)和Ser61Arg(2%)突变,这些突变与TAR有强烈相互作用,导致反式激活活性增强。分子动力学模拟数据证实,与野生型Tat以及缺乏Ser46Phe和Ser61Arg的其他变体相比,具有这种突变的变体对TAR具有更高的结合亲和力。Tat中的其他突变赋予了与TAR相互作用不同的亲和力,导致不同的反式激活能力。这是来自印度北部的首份报告,通过对CD4细胞计数的临床验证,证明了Tat基因变异对Tat稳定性及其与TAR相互作用的影响。这项研究突出了Tat与Tat活性的主要核苷酸的共同进化模式,有助于确定减弱病毒基因表达的遗传决定因素。